文献速递心境障碍

通过多项全基因组关联分析识别双相障碍与重性抑郁障碍之间的遗传差异

Identifying genetic differences between bipolar disorder and major depression through multiple genome-wide association analyses.
PubMed 文献 · Br J Psychiatry · 2025-01-14

基于精神疾病基因组学联盟共享的双相障碍与重性抑郁障碍病例对照队列个体基因型,构建含51149人(15532例双相障碍、12920例重性抑郁障碍、22697例对照)的病例-病例-对照队列进行多种全基因组关联分析与多基因风险评分分析。结果显示多基因风险评分可区分双相障碍与重性抑郁障碍(包括抑郁起病的双相障碍),并在独立丹麦队列(iPSYCH 2015,N=25966)中重复验证。作者认为重性抑郁障碍与双相障碍(含抑郁起病双相障碍)在遗传上不同,对照、重性抑郁障碍与双相障碍患者主要位于遗传风险连续谱上。

要点

  • 全基因组关联分析未充分把握检出全基因组显著位点,但发现显著芯片遗传力。
  • 多基因风险评分可区分双相障碍与重性抑郁障碍,包括抑郁起病的双相障碍。
  • 多基因风险评分结果在独立丹麦队列(iPSYCH 2015,N=25966)中重复验证。

核心结论

  • 重性抑郁障碍与双相障碍(包括抑郁起病的双相障碍)在遗传上不同。
  • 对照、重性抑郁障碍与双相障碍患者主要位于遗传风险连续谱上。
  • 未来样本量更大、信息更丰富的研究可能更好地理解这些发现,并有助于开发更好的遗传预测因子以区分双相障碍尤其是抑郁起病的双相障碍与重性抑郁障碍。

研究设计与样本

  • 基于精神疾病基因组学联盟共享的双相障碍与重性抑郁障碍病例对照队列个体基因型,经仔细质量控制后构建病例-病例-对照队列,共51149人(15532例双相障碍患者、12920例重性抑郁障碍患者、22697例对照)。
  • 在所得队列中进行多种全基因组关联分析与多基因风险评分分析。
  • 在独立丹麦队列(iPSYCH 2015,N=25966)中重复验证多基因风险评分结果。

主要发现

  • 全基因组关联分析未充分把握检出全基因组显著位点,但发现显著芯片遗传力。
  • 所得多基因风险评分可区分双相障碍与重性抑郁障碍,包括抑郁起病的双相障碍病例。
  • 多基因风险评分结果在独立丹麦队列(iPSYCH 2015,N=25966)中重复验证。
  • 病例-病例全基因组关联分析与病例-对照双相障碍全基因组关联分析之间观察到强遗传相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 全基因组关联分析未充分把握检出全基因组显著位点。
  • 未来需要样本量更大、信息更丰富的研究来更好地理解这些发现,并开发更好的遗传预测因子以区分双相障碍尤其是抑郁起病的双相障碍与重性抑郁障碍。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Accurate diagnosis of bipolar disorder (BPD) is difficult in clinical practice, with an average delay between symptom onset and diagnosis of about 7 years. A depressive episode often precedes the first manic episode, making it difficult to distinguish BPD from unipolar major depressive disorder (MDD). AIMS: We use genome-wide association analyses (GWAS) to identify differential genetic factors and to develop predictors based on polygenic risk scores (PRS) that may aid early differential diagnosis. METHOD: Based on individual genotypes from case-control cohorts of BPD and MDD shared through the Psychiatric Genomics Consortium, we compile case-case-control cohorts, applying a careful quality control procedure. In a resulting cohort of 51 149 individuals (15 532 BPD patients, 12 920 MDD patients and 22 697 controls), we perform a variety of GWAS and PRS analyses. RESULTS: Although our GWAS is not well powered to identify genome-wide significant loci, we find significant chip heritability and demonstrate the ability of the resulting PRS to distinguish BPD from MDD, including BPD cases with depressive onset (BPD-D). We replicate our PRS findings in an independent Danish cohort (iPSYCH 2015, N = 25 966). We observe strong genetic correlation between our case-case GWAS and that of case-control BPD. CONCLUSIONS: We find that MDD and BPD, including BPD-D are genetically distinct. Our findings support that controls, MDD and BPD patients primarily lie on a continuum of genetic risk. Future studies with larger and richer samples will likely yield a better understanding of these findings and enable the development of better genetic predictors distinguishing BPD and, importantly, BPD-D from MDD.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Panagiotaropoulou G, Hellberg KG, Coleman JRI, et al. Identifying genetic differences between bipolar disorder and major depression through multiple genome-wide association analyses. Br J Psychiatry. 2025. PMID: 39806801. doi:10.1192/bjp.2024.125

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。